Home Alyssa Hodder

How do you know if you should invest in a company or if it's overpriced?

  • April 22, 2015 September 13, 2019
  • 13:46

Can being healthier actually make you perform better at work?

  • April 17, 2015 September 13, 2019
  • 11:57

Did you know there are 600 lymph nodes in the human body—and 35 different lymphomas? "Lymphoma is one word but many diseases," said Robin Markowitz, CEO of Lymphoma Canada, at this year's GIPC event. "The patient's experience will vary accordingly."

  • April 15, 2015 September 13, 2019
  • 12:34

Last year was a tough one for Corby Spirit and Wine Ltd., a leading distributor of wine and spirits with 1,900 employees across Canada. The company, an affiliate of Pernod Ricard, has a 150+ year history and has had a lot of success. But, faced with a more challenging business environment, Pernod Ricard decided it […]

  • April 10, 2015 September 13, 2019
  • 11:07

Hepatitis C may not be on your radar as a drug plan sponsor. But with the benefits—and costs—of new therapies, it will be. Globally, there are 200 million people infected with hepatitis C. There’s a high burden of illness in developing countries such as Africa due to “medical misadventure” such as using unsterilized needles, explained […]

  • April 10, 2015 September 13, 2019
  • 11:05

The employee benefits industry has invested a lot of time and money in trying to understand millennials: how they interact with other generations, what they want and how best to reach them. But now there’s a new kid on the block: say hello to gen Z.

  • April 6, 2015 September 13, 2019
  • 07:00

Ever talk to an executive and have no idea what he or she is saying? Use our handy guide to corporate jargon to decipher it.

  • April 6, 2015 September 13, 2019
  • 07:00

Drugs continue to be a cost driver for benefits plans, so what should plan sponsors expect going forward?

  • March 25, 2015 September 13, 2019
  • 12:11

Although small-cap stocks may have underperformed recently, the bull market’s not over yet, and small caps should outperform large caps, said Jim Furey, managing partner and chief investment strategist with Furey Research Partners. He made the case for investing in U.S. small caps at a recent Pembroke Private Wealth Management luncheon. Read: Big rewards from […]

  • March 25, 2015 September 13, 2019
  • 11:24

The House of Commons recently passed Bill C-518, which would revoke the pensions of politicians who are convicted of certain serious crimes.

  • March 1, 2015 September 13, 2019
  • 07:00